ArticleFrontiers in oncology2023

2-Year survival benefit from immunotherapy for squamous cell cancer with cancer of unknown primary in mediastinum: a case report.

Wei Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.